ZAK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.955800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.604800E-01
Normal-vs-Stage2
7.265600E-01
Normal-vs-Stage3
4.133800E-01
Normal-vs-Stage4
1.368800E-01
Stage1-vs-Stage2
8.364200E-01
Stage1-vs-Stage3
3.529200E-01
Stage1-vs-Stage4
4.543600E-01
Stage2-vs-Stage3
7.67260000000825E-05
Stage2-vs-Stage4
5.073000E-01
Stage3-vs-Stage4
1.579950E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.333600E-01
Normal-vs-AfricanAmerican
2.334400E-01
Normal-vs-Asian
8.231400E-01
Caucasian-vs-AfricanAmerican
1.247750E-01
Caucasian-vs-Asian
8.239200E-01
AfricanAmerican-vs-Asian
5.278000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.598000E-01
Normal-vs-Female
7.098600E-01
Male-vs-Female
4.959200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.785000E-01
Normal-vs-Age(41-60Yrs)
5.721600E-01
Normal-vs-Age(61-80Yrs)
8.622200E-01
Normal-vs-Age(81-100Yrs)
9.779000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.874230E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.246200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.089600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.746200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.134200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.668200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.576400E-01
Normal-vs-Daily Drinker
6.335400E-01
Normal-vs-Weekly Drinker
6.860200E-01
Normal-vs-Occasional Drinker
9.102200E-01
Normal-vs-Social Drinker
5.944200E-01
Non Drinker-vs-Daily Drinker
4.855200E-01
Non Drinker-vs-Weekly Drinker
3.096200E-01
Non Drinker-vs-Occasional Drinker
8.891200E-01
Non Drinker-vs-Social Drinker
1.941410E-01
Daily Drinker-vs-Weekly Drinker
2.008200E-01
Daily Drinker-vs-Occasional Drinker
4.521200E-01
Daily Drinker-vs-Social Drinker
1.283770E-01
Weekly Drinker-vs-Occasional Drinker
3.457600E-01
Weekly Drinker-vs-Social Drinker
7.314400E-01
Occasional Drinker-vs-Social Drinker
2.162800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.160000E-01
Normal-vs-Grade 2
6.463200E-01
Normal-vs-Grade 3
6.178200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.784600E-01
Grade 1-vs-Grade 3
4.542800E-01
Grade 1-vs-Grade 4
9.160000E-01
Grade 2-vs-Grade 3
7.102600E-01
Grade 2-vs-Grade 4
6.463200E-01
Grade 3-vs-Grade 4
6.178200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.036600E-01
Normal-vs-NonDiabetic
9.060400E-01
Diabetic-vs-NonDiabetic
9.271000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.189200E-01
Normal-vs-NoPancreatitis
9.846800E-01
Pancreatitis-vs-NoPancreatitis
3.237400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.942000E-01
Normal-vs-N1
7.330000E-01
N0-vs-N1
1.639230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.376800E-01
Normal-vs-TP53-NonMutant
7.672400E-01
TP53-Mutant-vs-TP53-NonMutant
9.397800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
